News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion



6/25/2014 10:52:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AbbVie Inc. (ABBV), which was rejected on three different takeover offers for Shire Plc (SHP), may have to raise its bid to about 30 billion pounds ($51 billion) to persuade the drugmaker’s board to sell.

A proposal of about 51 pounds a share would do the trick, according to the average estimate of five analysts compiled by Bloomberg News. AbbVie’s latest cash-and-stock offer valued Shire at about 27.3 billion pounds.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES